Cure My Disease

Don't miss your cure!

 Log in / Sign up

App aims to help heart survivors eat, sleep, and socialize their way to better health

NCT ID NCT06601478

Disease control Sponsor: Universidad Autonoma de Madrid Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new online app that helps people who have had a heart attack or stroke follow a Mediterranean lifestyle — including diet, sleep, exercise, and social habits. About 80 to 100 adults in Spain will use the app for 8 months to see if it improves their health and reduces heart disease risk. The goal is to make healthy living easier to track and support in everyday medical care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age over 18 years and below 75 years. * Absence of language barriers * To be included in the cardiac rehabilitation programme * Capacity to comprehend, and answer the questionnaires, as well as to sign the informed consent. * Being a Spanish resident for a period of at least 1 year prior to the beginning of the study. * Not planning to permanently reside outside of Spain within the year. * Having suffered from a cardiovascular event (myocardial infarction, ictus, angina, ischemic cardiopathy). Exclusion Criteria: * Limitation to adhering to the recommendations. * Severe risk factors and/or with complicated control. * Chronic diseases not related to coronary disease (severe mental illness, congenital, susceptible to decompensation endocrinopathies, and gastrointestinal diseases with diarrhoea). * Patients that have an alternative private health insurance that doesn´t allow an electronic access to their data.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lifestyle are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lifestyle

Contacts and locations

Locations

  • Hospital Universitario Juan Ramón Jiménez

    Huelva, Andalusia, 21005, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.